Report Detail
Global (United States, European Union and China) Orally Disintegrating Tablet (ODT) Market Research Report 2019-2025
- RnM3640679 |
- 02 August, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
In 2019, the market size of Orally Disintegrating Tablet (ODT) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Orally Disintegrating Tablet (ODT).
This report studies the global market size of Orally Disintegrating Tablet (ODT), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Orally Disintegrating Tablet (ODT) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market Segment by Product Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Orally Disintegrating Tablet (ODT) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Orally Disintegrating Tablet (ODT) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Orally Disintegrating Tablet (ODT) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Orally Disintegrating Tablet (ODT) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Anti-Psychotics Drug
- 1.3.3 Anti-Epileptics Drug
- 1.3.4 Other
- 1.4 Market Segment by Application
- 1.4.1 Global Orally Disintegrating Tablet (ODT) Market Share by Application (2019-2025)
- 1.4.2 CNS Diseases
- 1.4.3 Gastrointestinal Diseases
- 1.4.4 CVS Diseases
- 1.4.5 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Orally Disintegrating Tablet (ODT) Market Size
- 2.1.1 Global Orally Disintegrating Tablet (ODT) Revenue 2014-2025
- 2.1.2 Global Orally Disintegrating Tablet (ODT) Sales 2014-2025
- 2.2 Orally Disintegrating Tablet (ODT) Growth Rate by Regions
- 2.2.1 Global Orally Disintegrating Tablet (ODT) Sales by Regions 2014-2019
- 2.2.2 Global Orally Disintegrating Tablet (ODT) Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Orally Disintegrating Tablet (ODT) Sales by Manufacturers
- 3.1.1 Orally Disintegrating Tablet (ODT) Sales by Manufacturers 2014-2019
- 3.1.2 Orally Disintegrating Tablet (ODT) Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Orally Disintegrating Tablet (ODT) Revenue by Manufacturers (2014-2019)
- 3.2.2 Orally Disintegrating Tablet (ODT) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Orally Disintegrating Tablet (ODT) Market Concentration Ratio (CR5 and HHI)
- 3.3 Orally Disintegrating Tablet (ODT) Price by Manufacturers
- 3.4 Key Manufacturers Orally Disintegrating Tablet (ODT) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Orally Disintegrating Tablet (ODT) Market
- 3.6 Key Manufacturers Orally Disintegrating Tablet (ODT) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Anti-Psychotics Drug Sales and Revenue (2014-2019)
- 4.1.2 Anti-Epileptics Drug Sales and Revenue (2014-2019)
- 4.1.3 Other Sales and Revenue (2014-2019)
- 4.2 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type
- 4.3 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type
- 4.4 Orally Disintegrating Tablet (ODT) Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Orally Disintegrating Tablet (ODT) Sales by Application
6 United States
- 6.1 United States Orally Disintegrating Tablet (ODT) Breakdown Data by Company
- 6.2 United States Orally Disintegrating Tablet (ODT) Breakdown Data by Type
- 6.3 United States Orally Disintegrating Tablet (ODT) Breakdown Data by Application
7 European Union
- 7.1 European Union Orally Disintegrating Tablet (ODT) Breakdown Data by Company
- 7.2 European Union Orally Disintegrating Tablet (ODT) Breakdown Data by Type
- 7.3 European Union Orally Disintegrating Tablet (ODT) Breakdown Data by Application
8 China
- 8.1 China Orally Disintegrating Tablet (ODT) Breakdown Data by Company
- 8.2 China Orally Disintegrating Tablet (ODT) Breakdown Data by Type
- 8.3 China Orally Disintegrating Tablet (ODT) Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Company
- 9.2 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Type
- 9.3 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Application
- 9.4 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Countries
- 9.4.1 Rest of World Orally Disintegrating Tablet (ODT) Sales by Countries
- 9.4.2 Rest of World Orally Disintegrating Tablet (ODT) Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Teva
- 10.1.1 Teva Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.1.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.1.5 Teva Recent Development
- 10.2 Merck
- 10.2.1 Merck Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.2.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.2.5 Merck Recent Development
- 10.3 Mylan
- 10.3.1 Mylan Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.3.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.3.5 Mylan Recent Development
- 10.4 Pfizer
- 10.4.1 Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.4.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.4.5 Pfizer Recent Development
- 10.5 Johnson and Johnson
- 10.5.1 Johnson and Johnson Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.5.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.5.5 Johnson and Johnson Recent Development
- 10.6 GSK
- 10.6.1 GSK Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.6.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.6.5 GSK Recent Development
- 10.7 Otsuka
- 10.7.1 Otsuka Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.7.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.7.5 Otsuka Recent Development
- 10.8 Eli Lilly and Company
- 10.8.1 Eli Lilly and Company Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.8.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.8.5 Eli Lilly and Company Recent Development
- 10.9 AstraZeneca
- 10.9.1 AstraZeneca Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.9.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.9.5 AstraZeneca Recent Development
- 10.10 Bristol-Myers Squibb
- 10.10.1 Bristol-Myers Squibb Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
- 10.10.4 Orally Disintegrating Tablet (ODT) Product Introduction
- 10.10.5 Bristol-Myers Squibb Recent Development
- 10.11 Conquer
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Orally Disintegrating Tablet (ODT) Sales Channels
- 11.2.2 Orally Disintegrating Tablet (ODT) Distributors
- 11.3 Orally Disintegrating Tablet (ODT) Customers
12 Market Forecast
- 12.1 Global Orally Disintegrating Tablet (ODT) Sales and Revenue Forecast 2019-2025
- 12.2 Global Orally Disintegrating Tablet (ODT) Sales Forecast by Type
- 12.3 Global Orally Disintegrating Tablet (ODT) Sales Forecast by Application
- 12.4 Orally Disintegrating Tablet (ODT) Forecast by Regions
- 12.4.1 Global Orally Disintegrating Tablet (ODT) Sales Forecast by Regions 2019-2025
- 12.4.2 Global Orally Disintegrating Tablet (ODT) Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Orally Disintegrating Tablet (ODT). Industry analysis & Market Report on Orally Disintegrating Tablet (ODT) is a syndicated market report, published as Global (United States, European Union and China) Orally Disintegrating Tablet (ODT) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Orally Disintegrating Tablet (ODT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
